Changes have been made in Uzbekistan regarding the procedure for including medicinal products in categories dispensed both by prescription and without one. The relevant regulatory act was approved by the Ministry of Justice.
These changes concern the refinement of criteria for listing medicinal products that can be sold over the counter. It is now possible to include in the category of non-prescription drugs medicines consisting of two or more active compounds.
When determining the possibility of dispensing a drug without a prescription, factors such as the therapeutic significance of each active substance, the benefit-risk ratio of the combination, its clinical justification, and the risks of mutual interaction, overdose, and improper use are taken into account.
If an application to move a drug from the prescription to the over-the-counter category is rejected, the applicant has the right to reapply within three years after eliminating the grounds for refusal or obtaining new information regarding the drug's safety and efficacy.
The authorized body may also review the drug's category based on new data on its safety and efficacy, pharmacovigilance and post-marketing surveillance results, as well as legislative changes.



